Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have a higher risk of heart disease.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Weight loss improves PCOS symptoms and overall health.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Effective weight loss during pregnancy is crucial for better maternal and fetal health.

PCOS is best managed with personalized lifestyle changes, medications, and sometimes surgery.

New therapies for rare skin diseases show promise but need more research.

RG and RJ gels speed up burn wound healing better than other treatments.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

GLP-1 agonists may increase the risk of hair loss.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

New therapies and treatments for hair disorders, especially in curly hair, show promise.

Weight-loss drugs are not linked to suicidal thoughts.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Lifestyle changes, medications, and fertility treatments can improve PCOS symptoms and prevent complications.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

Pharmacists play a crucial role in patient education and personalized care.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Oncogenic K-ras causes rapid cancerous changes in the mouth's lining.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

LGR5 mainly stays inside cells, moving to the trans-Golgi network, and this process is important for its role in cell signaling.

Lack of KSR1 stops certain skin tumors in mice.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Overexpression of LRIG3 in skin causes hair loss.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.